基于处方前置审核系统提高肿瘤专科合理用药水平

Improvement the Level of Rational Drug Use in Cancer Center Based on Pre-Prescription Review System

目的加强药学服务转型,通过处方前置审核,促进提高肿瘤专科合理用药水平。方法采用信息化手段,肿瘤药师结合肿瘤专科用药的特点,参与优化扩充适合专科医院用药知识库,加强与临床沟通,建立处方审核反馈机制完善审核知识库内容。结果全院以抗肿瘤药物为主的处方前置审核软件升级后,门诊及住院处方审核率分别从35.48%升至86.96%、12.34%升至91.88%、医生采纳率从4.35%升至28.13%,事后处方点评合格率从96.10%升至98.91%,尤其是适宜性及超常处方点评合格率显著提高,从70.90%升至98.75%。结论经整体升级优化处方前置审核系统适用于肿瘤专科医院,一定程度上减少用药错误的发生,规范医生用药行为,提高肿瘤专科合理用药水平。

OBJECTIVE To strengthen the transformation of pharmaceutical services,promote the improvement of rational drug use in cancer center through pre-prescription review system.METHODS By means of information technology,tumor pharmacists,in combination with the characteristics of drug use in cancer center,participated in the optimization and expansion of the knowledge base for anti-tumor drugs,strengthened communication with clinic,established a prescription review feedback mechanism,and improved the content of the review knowledge base.RESULTS After the upgrade of the pre-prescription review system mainly for antitumor drugs in the cancer center,the prescription review rate in outpatient and inpatient departments increased from 35.48%to 86.96%and 12.34%to 91.88%,respectively.The doctor's adoption rate increased from 4.35%to 28.13%,the post-prescription review qualified rate increased from 96.10%to 98.91%.In particular,the qualified rate of suitability supernormal prescriptions increased significantly,from 70.90%to 98.75%.CONCLUSION After upgrading and optimization,the pre-prescription review system is applicable to cancer center,which can reduce the occurrence of medication errors to a certain extent,standardize doctors'drug use behaviors,and improve the level of rational drug use in cancer center.